U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436234) titled 'A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis' on Feb. 03.
Brief Summary: This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe SAR
Study Start Date: March 02
Study Type: INTERVENTIONAL
Condition:
Seasonal Allergic Rhinitis
Intervention:
DRUG: AK139
AK139 regimen 1- subcutaneous injection.
DRUG: AK139
AK139 regimen 2- subcutaneous injection
DRUG: Placebo
Placebo-subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Akeso
Published by HT Digita...